Dutton Associates Featured Company: ImaRx Therapeutics, Inc. (IMRX)
ImaRx Therapeutics, Inc. is a biopharmaceutical company engaged in developing and commercializing therapies for vascular disorders in the United States. The company’s operations are focused in two main areas. First, the company generates revenue from the sale of urokinase, a thrombolytic drug used for the treatment of acute massive pulmonary embolism, or blood clots in the lungs. The company sells urokinase to wholesale distributors under the Kinlytic brand name. The company uses the revenue from urokinase to fund its SonoLysis clinical program. The company's research and development efforts are focused on using its proprietary microbubble technology in conjunction with focused…